Viral type | Baseline | Clearance | Reinfection | ||||||
---|---|---|---|---|---|---|---|---|---|
Prevalence% (n=) [95% CI] | Viral load, median (IQR) | Rate* [95% CI] | Total HPV viral load**, median (IQR) | % (n=) [95% CI] | Viral load, median (IQR) | ||||
Absolut | Normalised | Absolut | Normalised | Absolut | Normalised | ||||
HPV-16 | 71.2% (156) [64.7-77.1] | 2.9E + 6 (9.7E + 6) | 0.2 (6.7) | 5.9 [4.9-7.2] | 2.17E + 09 (7.67E + 10) | 5 (13,468) | 48.6% (53) [39–58] | 2.9E + 6 (9.2E + 6) | 0.32 (5.3) |
HPV-18 | 53% (116) [46.1-59.7] | 4.3E + 6 (4.56E + 07) | 0.42 (13) | 1.76 [1.3-2.4] | 6.56E + 09 (6.34E + 11) | 208 (30,101) | 12% (7.4-20.4) | 3.0E + 6 (4.28E + 07) | 0 .1 (1.8) |
HPV-31 | 37% (81) [30.6-43.8] | 9.04E + 07 (6.29E + 09) | 44 (3,360) | 2.75 [1.96-3.84] | 1.23E + 07 (3.02E + 07) | 7 (96) | 50% (17) [32–67] | 1.96E + 09 (7.61E + 09) | 3,360 (12,400) |
HPV-33 | 6.4% (14) [3.5-10.5] | 2.96E + 07 (1.14E + 09) | 3.6 (39,100) | 11.51 [6.7-19.8] | 1.39E + 9 (1.91E + 10) | 774 (4,683) | 38.5% (5) [14–68] | 1.47E + 08 (5.82E + 08) | 51 (128) |
HPV-45 | 43.4% (95) [36.7-50.2] | 2.48E + 06 (1.12E + 09) | 0.33 (180) | 5 [3.9-6.42] | 1.84E + 08 (9.30E + 11) | 18 (1E + 05) | 43.5% (27) [30.9-56.7] | 1.14E + 08 (1.94E + 09) | 17 ( 7,180) |
HPV-58 | 45.7% (100) [38.9-52.5] | 6.14E + 05 (2.1E + 06) | 0.4 (15.7) | 4.05 [3.1-5.24] | 4.35e + 08 (5.92e + 10 ) | 141 (5,749) | 0 | 0*** | 0 |